PTTG1IP and breast carcinoma: As analysed in a material comprising of all breast cancer subtypes (n = 401), breast carcinomas lacking PTTG1IP immunoexpression and particularly the lack of PTTG1IP expression in combination with high securin expression were associated with an increased risk of breast cancer death.